EVER Pharma Launches a Digital Training App for the D-mine® Pump
After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER Pharma developed an App to support the training needs of Healthcare Professionals and caregivers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220712005103/en/
EVER Pharma, a specialist in neurological diseases, offers a complete therapy package for Parkinson’s disease with D-mine ® Pump , D-mine ® Pen and Dacepton® (Dopaceptin® , Apomorphine hydrochloride) and with its new D-mine ® Pump TRAINING APP a simulation tool to support the training and the programing of the D-mine ® Pump.
The App can be easily downloaded and installed onto Android or iOS devices by Healthcare Professionals or caregivers who are working with the D-mine ® Pump and managing the therapy of Parkinson´s patients with infusion therapy.
“With the development of the TRAINING APP for the D-mine ® Pump in Parkinson's therapy, we now have an empowering and interactive tool to support the training of the Healthcare Professionals and caregivers on how to use and program the infusion pump device. The App is an intuitive, easy-to-use simulator and enables training any time everywhere”, explains Georges Kahwati, General Manager at EVER Pharma GmbH.
For more information please visit www.d-minecare.com .
About EVER Pharma GmbH
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production and commercialization of products in the areas of neurology, critical care, anesthesia and oncology.
From its global headquarters in Austria, Ever Pharma provides innovative therapies and value-added formulations aimed at enhancing patient and healthcare professional’s lives through improved safety and convenience.
The products are developed and manufactured at EU GMP certified facilities in Austria and Germany. The technical operations are highly specialized in the production of complex injectables including high potency substances, crystal suspensions, oily solutions and controlled substances in vials, pre-filled syringes, cartridges, ampoules and implants. EVER markets its products in more than 80 countries around the world through 30 international affiliated companies and strategic partners.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IL-ISACA10.8.2022 08:32:06 CEST | Press release
New IT Audit Fundamentals Certificate from ISACA Helps Professionals Launch Careers
SMITHS-DETECTION10.8.2022 08:02:27 CEST | Press release
Smiths Detection equips Leonardo di Vinci International Airport in Rome with advanced carry-on baggage screening technology
LENOVO-GROUP10.8.2022 01:43:09 CEST | Press release
Lenovo Group: First Quarter Results 2022/23
NY-PHILIP-MORRIS-INTL9.8.2022 22:16:11 CEST | Press release
Philip Morris Holland Holdings B.V. Extends the Acceptance Period for the Recommended Cash Offer to the Shareholders of Swedish Match AB Until October 21, 2022
NY-THE-GOOD-SOCIETY9.8.2022 19:02:10 CEST | Press release
Nonprofit Funding Platform Heroe5 Launches The Good Society, Embracing Web3 Approach to the Sustainable Financial Benefit for Charities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom